Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,037,646
in 4 filings

Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-31 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −1,334 0
2025-01-31 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −3,333 3,334
2025-01-31 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −3,333 6,667
2025-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Restricted Stock Units +20,000 20,000
2025-01-31 Smith Jason Drew General Counsel Option exercise +2,500 27,726
2025-01-31 Smith Jason Drew General Counsel Sale −1,258 $11.14 $14K 26,468
2025-01-31 Smith Jason Drew General Counsel Option exercise +6,667 33,135
2025-01-31 Smith Jason Drew General Counsel Sale −3,354 $11.14 $37K 29,781
2025-01-31 Smith Jason Drew General Counsel Option exercise +5,500 35,281
2025-01-31 Smith Jason Drew General Counsel Sale −2,767 $11.14 $31K 32,514
2025-01-31 Smith Jason Drew General Counsel Option exercise · Restricted Stock Units −2,500 0
2025-01-31 Smith Jason Drew General Counsel Option exercise · Restricted Stock Units −6,667 6,667
2025-01-31 Smith Jason Drew General Counsel Option exercise · Restricted Stock Units −5,500 11,000
2025-01-31 Smith Jason Drew General Counsel Grant or award · Restricted Stock Units +10,000 10,000
2025-01-31 Barrett Elizabeth A. Chief Executive Officer Grant or award · Restricted Stock Units +96,377 96,377
2024-10-08 Degnan Chris Chief Financial Officer Grant or award · Restricted Stock Units +13,450 13,450
2024-10-08 Degnan Chris Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +74,142 74,142
2024-09-09 Schoenberg Mark Chief Medical Officer Option exercise +1,666 145,950
2024-09-09 Schoenberg Mark Chief Medical Officer Sale −859 $13.08 $11K 145,091
2024-09-09 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −1,666 3,334

Page 6 of 13 · 244 trades